SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Debt | ₹72 Cr | ₹83 Cr | ₹58 Cr | ₹12 Cr | ₹5.62 Cr |
What is the latest Total Debt ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Debt |
---|---|
Mar2024 | ₹72 Cr |
Mar2023 | ₹83 Cr |
Mar2022 | ₹58 Cr |
Mar2017 | ₹12 Cr |
Mar2016 | ₹5.62 Cr |
How is Total Debt of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹72 Cr | -12.86 | |
Mar2023 | ₹83 Cr | 43.94 | |
Mar2022 | ₹58 Cr | 364.15 | |
Mar2017 | ₹12 Cr | 121.47 | |
Mar2016 | ₹5.62 Cr | - |
Compare Total Debt of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,719.3 Cr | 1.2% | -3.1% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 1.2% |
-3.1% |
14.1% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses